Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs SK Hynix (SKHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs SK Hynix — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $57 (market cap $25.27B), while SK Hynix trades at $170.5 (market cap $891.31B). The key difference: SK Hynix is far larger — about 35.3× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and SK Hynix for 10 Days on average.
| RPRX | SKHY | |
|---|---|---|
Market Cap | $25.27B | $891.31B |
Volume | 3,671,183 | 22,268,296 |
Sector | Health | Technology |
52-Week High | $63.96 | $198.63 |
52-Week Low | $35.44 | $126.79 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $32.50B | $841.45B |
Dividend Yield | 1.66% | 0.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About SK Hynix
SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →
